These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8426494)

  • 61. [Familial hypercholesterolemia in a homozygote and LDL kinetics].
    Obando Santaella I; Fernández Gómez E; Mongil Ruiz I; Escobar Gallego A; Espino Aguilar R
    An Esp Pediatr; 1991 Jul; 35(1):71-2. PubMed ID: 1772179
    [No Abstract]   [Full Text] [Related]  

  • 62. [Treatment difficulty in familial homozygous hypercholesterolemia].
    Gilsanz Peral A; Dalmau Serra J; Bretó Gilabert M
    Med Clin (Barc); 1992 Jun; 99(2):78. PubMed ID: 1630191
    [No Abstract]   [Full Text] [Related]  

  • 63. [Homozygous familial hypercholesterolemia (author's transl)].
    Nervi F; Arteaga A; Maiz A; Tocornal J; Severin MC
    Rev Med Chil; 1979 Jul; 107(7):624-8. PubMed ID: 232560
    [No Abstract]   [Full Text] [Related]  

  • 64. Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022.
    Harada-Shiba M; Arai H; Ohmura H; Okazaki H; Sugiyama D; Tada H; Dobashi K; Matsuki K; Minamino T; Yamashita S; Yokote K
    J Atheroscler Thromb; 2023 May; 30(5):558-586. PubMed ID: 36682773
    [No Abstract]   [Full Text] [Related]  

  • 65. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia.
    Stoffel W; Borberg H; Greve V
    Lancet; 1981 Nov; 2(8254):1005-7. PubMed ID: 6118475
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Heparin-sorbent for low density lipoproteins removal in hypercholesterolemia.
    Sinitsyn VV; Metlitscaya LM; Mamontova AG; Konovalov GA; Kukharchuk VV
    Biomater Artif Cells Artif Organs; 1990; 18(5):629-35. PubMed ID: 2099218
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long-term follow-up of carotid atherosclerosis in patients with heterozygous familial hypercholesterolemia under LDL apheresis treatment.
    Donner MG; Richter WO; Schwandt P
    J Clin Apher; 1997; 12(4):202-3. PubMed ID: 9483185
    [No Abstract]   [Full Text] [Related]  

  • 68. [Kinetic value of LDL in familial hypercholesterolemia].
    Sáenz Aranzubia P; Piñan Lopez E
    An Esp Pediatr; 1991 Mar; 34(3):252-3. PubMed ID: 2064159
    [No Abstract]   [Full Text] [Related]  

  • 69. [Atheromatous carotid artery changes in familial hypercholesterolemia before and following therapy].
    Spengel FA; Keller C
    Vasa Suppl; 1991; 33():52-4. PubMed ID: 1788761
    [No Abstract]   [Full Text] [Related]  

  • 70. Homozygous familial hypercholesterolaemia.
    Macchiaiolo M; Gagliardi MG; Toscano A; Guccione P; Bartuli A
    Lancet; 2012 Apr; 379(9823):1330. PubMed ID: 22285056
    [No Abstract]   [Full Text] [Related]  

  • 71. Selenium deficiency in hypercholesterolaemic patients treated with LDL apheresis.
    Jaudon MC; Assogba U; Bourely B; Dairou F; Bruckert E; Delattre J
    Lancet; 1994 May; 343(8906):1160. PubMed ID: 7910247
    [No Abstract]   [Full Text] [Related]  

  • 72. NLA symposium on familial hypercholesterolemia. Question-and-answer session.
    McGowan M; Defesche ; Whayne T; Tanner JR; Hemphill ; Carimi S; Hopkins ; Goldberg
    J Clin Lipidol; 2010; 4(5):357-8. PubMed ID: 21122678
    [No Abstract]   [Full Text] [Related]  

  • 73. Low density lipoprotein apheresis: a selective plasma separation method.
    Bambauer R
    Artif Organs; 1996 Apr; 20(4):284-5. PubMed ID: 8860707
    [No Abstract]   [Full Text] [Related]  

  • 74. Complement activation during low-density lipoprotein apheresis.
    Tridon A; Palcoux JB; Jouanel P; Bezou MJ; Coulet M; Betail G
    Artif Organs; 1992 Dec; 16(6):577-85. PubMed ID: 1482327
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [LDL-apheresis for refractory nephrotic syndrome].
    Muso E
    Nihon Jinzo Gakkai Shi; 2010; 52(7):928-33. PubMed ID: 21077343
    [No Abstract]   [Full Text] [Related]  

  • 76. Use of losartan in FH patients during treatment with DSC-LDL apheresis.
    Pintus S; Pintus P; Maxia P; Anedda S
    J Clin Apher; 1997; 12(3):156. PubMed ID: 9365870
    [No Abstract]   [Full Text] [Related]  

  • 77. Prevention with icatibant of anaphylactoid reactions to ACE inhibitor during LDL apheresis.
    Davidson DC; Peart I; Turner S; Sangster M
    Lancet; 1994 Jun; 343(8912):1575. PubMed ID: 7911901
    [No Abstract]   [Full Text] [Related]  

  • 78. Comparison of plasmafractionation filters and filtration techniques in the clinical practice of LDL-apheresis.
    Kochinke F; Baeyer HV; Schwaner I; Schwerdtfeger R
    ASAIO Trans; 1986; 32(1):388-91. PubMed ID: 3778740
    [No Abstract]   [Full Text] [Related]  

  • 79. Progression of atheroma in homozygous familial hypercholesterolaemia during regular plasma exchange.
    Leonard JV; Clarke M; Macartney FJ; Slack J
    Lancet; 1981 Oct; 2(8250):811. PubMed ID: 6116939
    [No Abstract]   [Full Text] [Related]  

  • 80. Organization and technical problems of LDL-apheresis.
    Scarpato N; Falco C; Nappi G; Formisano S
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():165-7. PubMed ID: 8013980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.